Jean-Pascal Conduzorgues

City:

Montpellier

Country:

France

Published Applications:

Last publication date:

2023-05-18

Top Assignees for applications by Jean-Pascal Conduzorgues

The entities that hold a legal rights for patent applications filed by inventor Conduzorgues Jean-Pascal:

GENE SIGNAL INTERNATIONAL SA 2 Lausanne, Switzerland
OSE Immunotherapeutics 2 Nantes, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
ASSISTANCE PUBLIQUE -HÔPITAUX DE PARIS (APHP) 1 Paris, France
FONDATION IMAGINE 1 Paris, France
UNIVERSITE PARIS SACLAY 1 Gif sur Yvette, France
UNIVERSITÉ PARIS CITÉ 1 Paris, France
LABORATOIRES C.T.R.S. 1 Boulogne-Billancourt, France
GENE SIGNAL INTERNATIONALSA 1 Lausanne, Switzerland

Recent patent applications by Conduzorgues Jean-Pascal

Jean-Pascal Conduzorgues from Montpellier, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-18

US20230149405A1

Human necessities

TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN

#2 | 2022-08-18

US20220259277A1

Chemistry; metallurgy

Method for manufacturing a stable emulsion for peptide delivery

#3 | 2019-11-14

US20190345213A1

Chemistry; metallurgy

Method for manufacturing a stable emulsion for peptide delivery

#4 | 2015-10-08

US20150283165A1

Human necessities

USE OF AN INHIBITOR OF IRS-1 FOR TREATING SKIN DISORDERS

#5 | 2014-01-09

US20140011858A1

Chemistry; metallurgy

Inhibitor of IRS-1 for treating skin disorders

#6 | 2013-06-06

US20130143947A1

Human necessities

Injectable Pharmaceutical Composition for Preventing, Stabilising and/or Inhibiting Pathological Neovascularization-Related Conditions

#7 | 2012-02-16

US20120041047A1

Human necessities

Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions

InventorID:

276253 ⎘